Therapies
Monday, November 18th, 2013
AHA: 11/12/13 Preamble and Transition to ACC/AHA Guidelines to Reduce Cardiovascular Risk The goals of the American College of Cardiology (ACC) and the American Heart Association (AHA) are to prevent cardiovascular (CV) diseases, improve the management of people who have these diseases through professional education and research, and develop guidelines, standards and policies that promote […]
Therapies
Monday, November 18th, 2013
AMA: 11/12/13 Preamble and Transition to ACC/AHA Guidelines to Reduce Cardiovascular Risk The goals of the American College of Cardiology (ACC) and the American Heart Association (AHA) are to prevent cardiovascular (CV) diseases, improve the management of people who have these diseases through professional education and research, and develop guidelines, standards and policies that promote […]
Therapies
Monday, November 18th, 2013
Ohio State: 11/6/2013 COLUMBUS, Ohio – Researchers at The Ohio State University Wexner Medical Center have developed a therapeutic at-home gaming program for stroke patients who experience motor weakness affecting 80 percent of survivors. Hemiparesis affects 325,000 individuals each year, according to the National Stroke Association. It is defined as weakness or the inability to move […]
Therapies
Tuesday, November 12th, 2013
Wiley: 11/10/13 Background and Purpose Intravenous tissue plasminogen activator is the most effective treatment for acute ischemic stroke, and its use may therefore serve as an indicator of the available level of acute stroke care. The greatest burden of stroke is in low- and middle-income countries, but the extent to which intravenous tissue plasminogen activator is […]
Therapies
Tuesday, November 12th, 2013
Wiley: 11/10/13 It remains unclear whether occlusion site impacts outcome in patients with acute carotid artery occlusions. Methods Patients with acute carotid artery occlusion that underwent endovascular reperfusion treatments were prospectively enrolled. Patients with extracranial carotid bifurcation occlusions were compared with those with intracranial carotid-T-occlusions. Collected data included demographics, risk factor profile, and procedure-related variables. Neurological […]
Therapies
Tuesday, November 12th, 2013
J NeuroIntervent Surg: 11/6/13 Every year almost 800 000 people in the USA suffer a new or recurrent stroke, and stroke is the third leading cause of death with over 140 000 deaths in the USA in 1995.1 Additionally, stroke is a leading cause of long-term disability with an estimated cost of $68.9 billion in 2009. The relationship between […]
Therapies
Tuesday, November 12th, 2013
STROKEAHA: November 5, 2013 Research Priorities in the Assessment of Neurothrombectomy Devices ackground and Purpose—The goal of the Stroke Treatment Academic Industry Roundtable (STAIR) meetings is to advance the development of stroke therapies. At STAIR VIII, consensus recommendations were developed for clinical trial strategies to demonstrate the benefit of endovascular reperfusion therapies for acute ischemic stroke. […]
Therapies
Tuesday, November 12th, 2013
Neurology: 11/1/13 Objective: We aimed to compare the rates of thrombolysis utilization for acute ischemic stroke in hospitals with neurology residency (NR) to those of other teaching (OT) and nonteaching (NT) hospitals. Methods: A retrospective serial cross-sectional cohort study of a nationally representative sample of stroke patients was conducted. Accreditation Council for Graduate Medical Education–accredited NR program–affiliated hospitals […]
Therapies
Monday, November 4th, 2013
STROKEAHA: October 30, 2013 Background and Purpose—Women are more likely to have a worse outcome after an acute stroke than men. Some studies have suggested that women also benefit less from intravenous thrombolysis after an acute ischemic stroke, but others found no sex differences in safety and efficacy. We aimed to evaluate differences in 3-month outcome […]
Therapies
Monday, November 4th, 2013
STROKEAHA: October 30, 2013 Background and Purpose—The brush sign (BS) is the enlargement of medullary veins on 3-T T2*-weighted MRI seen in patients with ischemic stroke because of major cerebral artery occlusion. However, the clinical relevance of BS in patients with acute stroke remains unclear. We assessed the correlation between detecting BS with the development of […]
